vimarsana.com
Home
Live Updates
Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023 : vimarsana.com
Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
EQS-News: Biotest AG
/ Key word: 9 Month figures
Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
02.11.2023 / 08:00 CET/CEST
The issuer...
Related Keywords
Spain
,
Hanover
,
Niedersachsen
,
Germany
,
Dreieich
,
Hessen
,
United Kingdom
,
Berlin
,
Munich
,
Bayern
,
Barcelona
,
Comunidad Autonoma De Cataluna
,
United States
,
Frankfurt
,
Brandenburg
,
German
,
Dirk Neum
,
Monika Baumann Buttkereit
,
Biotest Group
,
Grifols Group
,
Standard Of The German Stock Exchange
,
Drug Administration
,
Biotest Next Level
,
Biotest Next
,
Biologics License Application
,
Igg Next Generation
,
Quarterly Reports
,
Prime Standard
,
German Stock
,
Monika Baumann
,
Markets
,
vimarsana.com © 2020. All Rights Reserved.